Subscribe To
biotech stock surges on mid-stage drug trial success
The shares of 89bio Inc ( NASDAQ:ETNB) are up 38.2% to trade at $15.11 at last check, after the biotech ...
March 22, 2023, 10:49 am
89bio rockets 30% — and akero dives — on a scorching battle in liver disease
Small biotech company 89bio scored a win Wednesday in fatty liver disease, and ETNB stock rocketed well...
March 22, 2023, 9:14 am
Want diversified upside in biotechnology? check out labu
Watch the Direxion Daily S&P 500 biotech Bull 3X Shares (NYSEARCA: LABU) if you want a speculative play...
March 22, 2023, 9:01 am
Indaptus therapeutics to present at the investor summit conference
NEW YORK, March 22, 2023 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP), a biotechnology company focused on discovering and developing...
March 22, 2023, 8:00 am
Vigil neuroscience to present at stifel 2023 cns days
WATERTOWN, Mass., March 22, 2023 (GLOBE NEWSWIRE) -- Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to har...
March 22, 2023, 7:00 am
Kineta to present vista biomarker data at aacr annual meeting 2023
SEATTLE, March 22, 2023 (GLOBE NEWSWIRE) -- Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immu...
March 22, 2023, 6:30 am
Wall street absolutely loved this biotech stock. but it just crashed more than 50%.
Analysts had lofty expectations for Altimmune and the prospects for pemvidutide in treating obesity. However, pemvidutide's side effects in a phase 2 ...
March 22, 2023, 5:55 am
4 biotech stocks to consider for your portfolio in 2023
New drug approvals and pipeline progress should maintain the momentum for the Zacks Biomedical and Genetics industry. A strong portfolio and a solid p...
March 21, 2023, 1:00 pm
The 3 most promising biotech stocks to buy now
This year the National Institutes of Health is set to request its biggest budget yet for 2024, on the heels of its previous biggest budget in 2023. As...
March 21, 2023, 9:00 am
Humacyte to present fourth quarter and full year financial results and provide corporate update on march 24, 2023
DURHAM, N.C., March 21, 2023 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally...
March 21, 2023, 8:01 am
Why exelixis stock leaped more than 4% higher today
The biotech announced a shareholder-pleasing bit of financial engineering. This will total as much as $...
March 20, 2023, 7:11 pm
Why macrogenics stock inched higher on monday
Two analysts raised their price targets on the cancer-focused biotech. They are the latest prognosticators to adjust their takes on the company follow...
March 20, 2023, 6:59 pm
Illumina shares attractive as conclusion to grail saga draws closer, broker says
Analysts at Canaccord Genuity (TSX:CF, LSE:CF) have reiterated their ‘Buy' rating for Illumina Inc (NASDAQ:ILMN) following recent activism efforts a...
March 20, 2023, 3:01 pm
3 dow stocks near 52-week lows that look like bargains now
With 60 years of consecutive annual raises, Johnson & Johnson is one of the most reliable dividend-paying stocks the world has ever known. Amgen is a ...
March 20, 2023, 6:23 am
3 (good) reasons warren buffett doesn't invest in biotech stocks
If you're a conservative investor like Buffett, it makes sense to avoid the industry. Biotechs are risky, unreliable, and sometimes have trouble locki...
March 19, 2023, 9:45 am
Icahn proposes three candidates for illumina's board — here's what could be next in the battle
A fight has broken out between veteran activist Carl Icahn and biotech company Illumina as the investor...
March 18, 2023, 8:39 am
1 green flag and 1 red flag for novavax
Novavax missed out on the first big wave of vaccine demand -- and that's weighed on the company's progress. Now, the ...
March 18, 2023, 5:30 am
Why macrogenics stock tumbled today
An analyst downgraded his recommendation on the cancer-focused biotech. It seemed post-earnings profit-taking also played a role in the selloff....
March 17, 2023, 6:15 pm
Celyad oncology to announce full year 2022 financial results and host conference call
MONT-SAINT-GUIBERT, Belgium, March 17, 2023 (GLOBE NEWSWIRE) -- Celyad Oncology (Euronext & Nasdaq: CYAD) (the “Company”), a biotechnology company...
March 17, 2023, 5:01 pm
Medicare negotiation undercuts biotech stocks regeneron, halozyme
Confusion over new Centers for Medicare and Medicaid Services negotiating plans sent REGN and HALO stocks tumbling Thursday. The post Medicare Negotia...
March 17, 2023, 10:50 am